THE FDA APPROVED TUMOR TREATING FIELDS FOR THE TREATMENT OF PATIENTS WITH RECURRENT GBM IMPORTANTLY IT WAS THE FIRST TIME EVER THAT THE FDA INCLUDED IN THEIR APPROVAL OF AN ONCOLOGY TREATMENT A QUALITY